GovChime
Notice ID: e0255f3ec82b4f8aa7ad1ac6ed248da5SolicitationArchived

Federal Occupational Health - Medications, Vaccines, and Medical Supplies (MVMS)

Archived on August 22, 2026. Original response deadline: . Full description on SAM.gov.

Overview

Response deadline
12:00 PM EDT
Posted
August 5, 2026
Notice type
Solicitation
Set-aside
No Set aside used
NAICS
424210: Drugs and Druggists' Sundries Merchant Wholesalers
Agency
Department of Health and Human ServicesOFFICE OF THE ASSISTANT SECRETARY FOR ADMINISTRATION (ASA)

Notice details

Office
PROGRAM SUPPORT CENTER ACQ MGMT SVC
Place of performance
Rockville, Maryland, 20852
Last updated
Oct 28, 2026
First published
Last updated on SAM.gov

Identifiers

Solicitation number
7571MN26R00026
Notice ID
e0255f3ec82b4f8aa7ad1ac6ed248da5

Description

Solicitation 7571MN26R00026 - Amendment 0002

The purpose of this amendment is to extend the proposal submission deadline from 5:00 p.m. Eastern 
Time (ET) on Wednesday, August 5, 2026, to 12:00 p.m. Eastern Time (ET) on Friday, August 7, 2026.

All other terms and conditions of Solicitation 7571MN26R00026 remain unchanged.
________________________________________________________

Solicitation 7571MN26R00026 - Amendment 0001

The purpose of this amendment is to publish responses to vendor questions received by the inquiry deadline. All other terms
and conditions of Solicitation 7571MN26R00026 remain unchanged.

NOTE: 

QUESTIONS: All questions/inquiries concerning the solicitation document must be submitted by e-mail (no faxes or telephone calls please) to the Contract Specialist, no later than July 25, 2026, at 5:00pm Eastern Time (ET). Questions should be e-mailed to the following address: Chaunda.Stewart@hhs.gov. **Submission dates and times will not be extended. **

PROPOSALS:  Proposals must be submitted no later than August 5, 2026, at 5:00 pm Eastern Time (ET).

Objective

The objective of this Pre-solicitation Notice (Notice) is to inform the vendor community that the U.S. Department of Health & Human Services (HHS) Federal Occupational Health (FOH) Department intends to release a Request for Proposals (RFP) for medications, vaccines and medical supplies. NOTE: The posting of the Pre-solicitation Notice is for vendor planning purposes only. This pre-solicitation notice in no way obligates HHS to issue the referenced solicitation. HHS does not guarantee the issuance of the solicitation nor that the information contained in the Pre-solicitation Notice will remain unchanged upon issuance of the solicitation.

Purpose

The purpose of this contract is to acquire medications, vaccines and medical supplies (MVMS) for Federal Occupational Health (FOH) locations through a nationwide, contractor managed web-based ordering portal to support the Program Support Center under the Department of Health and Human Services. This contract aims to consolidate operations, offering a more convenient, reliable and cost-effective approach to MVMS procurement. Additionally, the contract will enhance FOH’s ability to maintain comprehensive oversight of MVMS procurement activities. This requirement is a commercial service and will utilize FAR Part 12/15, as supplemented. The Government intends to issue a single award for a period not to exceed five (5) years.

Background

Federal Occupational Health (FOH) improves the health, safety, and productivity of the federal workforce. As the largest provider of occupational health services in the federal government, FOH supports more than 300 federal entities and over one million federal employees nationwide, including the District of Columbia and U.S. Territories. FOH delivers comprehensive occupational health services and consultation through Interagency Agreements (IAAs) with federal departments and agencies at the national, regional, and local levels. Services range from core occupational health and safety programs to structured clinical, wellness, behavioral health, and environmental health solutions. FOH retains sole responsibility for consulting with customer agencies, while the contractor facilitates delivery of services outlined in the Performance Work Statement (PWS) as well as the solicitation found in the attachments section.  

FOH sets the standard for promoting a culture of health and safety across the federal workforce. Program effectiveness depends on the expertise and performance of contractor-managed operations, including procurement of Medications, Vaccines and Medical Supplies (MVMS). Historically, FOH has sourced MVMS from multiple vendors, including the Program Support Center’s fulfillment center. This contract will consolidate MVMS procurement into a more efficient, reliable, and cost-effective model; reduce reliance on government purchase cards and unstable supply chains; and strengthen FOH oversight of procurement activities.

Please ensure all documents attached to this solicitation read throughly.  

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Contracting Officer

Primary Contact

Secondary Contact

Documents

Files (11)

  • SF30 Amendment 0002 MVMS.pdf

    677 KBAdded in Solicitation version 7Posted
    Download
  • Solicitation_7571MN26R00026_Questions_Answers_7_28_2026.xlsx

    20 KBAdded in Solicitation version 5Posted
    Download
  • SF30_Amendment_0001_MVMS_CO_Signed.pdf

    648 KBAdded in Solicitation version 5Posted
    Download
  • Attach J.5 Past Perform.docx

    22 KBAdded in Solicitation version 4Posted
    Download
  • Attach J.1 Product List.xlsx

    42 KBAdded in Solicitation version 4Posted
    Download
  • Attach J.7 Cntr Self Assess.docx

    30 KBAdded in Solicitation version 4Posted
    Download
  • Attach J.4 Offeror Checklist.docx

    23 KBAdded in Solicitation version 4Posted
    Download
  • Attach J.3 Product Cap Matrix.xlsx

    27 KBAdded in Solicitation version 4Posted
    Download
  • Attach J.6 Finan Cap Wrk.docx

    21 KBAdded in Solicitation version 4Posted
    Download
  • Attach-J.2 Pricing Worksheet.xlsx

    49 KBAdded in Solicitation version 4Posted
    Download
  • Solicitation MVMS v5.pdf

    718 KBAdded in Solicitation version 4Posted
    Download

Lifecycle

  1. 3
    Version 3PresolicitationArchived

    Federal Occupational Health - Medications, Vaccines, and Medical Supplies (MVMS)

    Notice cde398d0c82d4a3996fd15d187aab683 on SAM.gov

  2. 4
    Version 4SolicitationArchived

    Type changed from Presolicitation to Solicitation

    Federal Occupational Health - Medications, Vaccines, and Medical Supplies (MVMS)

    Notice daa50bdcf3b245cea256fc0de820838d on SAM.gov

  3. 5
    Version 5SolicitationArchived

    Federal Occupational Health - Medications, Vaccines, and Medical Supplies (MVMS)

    Notice 5f1d4c14ef0d413ab3dcf57d0ed50a2a on SAM.gov

  4. 7
    Version 7SolicitationArchivedCurrent

    Federal Occupational Health - Medications, Vaccines, and Medical Supplies (MVMS)

    Notice e0255f3ec82b4f8aa7ad1ac6ed248da5 on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline
Annual delivery order issued on a sole-source basis from the Department of Veteran’s Affairs Glaxosmith Kline federal supply schedule for pharmaceuticals and vaccines. The specific contract number is 36F79722D0178. The delivery order will be for proprietary Fluarix and Flulaval Influenza vaccines.
42%
Sole Source / J&AOpen
Bausch Health US, LLC Award 09/30/2026 - 09/30/2031
38%
AwardedOpen
Acquisition Description: This is a Notice of Intent, not a request for proposal. The National Institute of Health, Clinical Center (NIH-CC) intends to negotiate on an other than full and open competition basis with Takeda Pharmaceutical Company Limited. The National Institutes of Health (NIH) Clinical Center (CC) is a clinical research hospital providing all medical services for patients participating in human research protocols of the NIH. The CC Pharmacy department provides a range of pharmaceutical care services to inpatients and outpatients enrolled in clinical trials. The CC Pharmacy department is responsible for acquiring the supply of medications required for patient care. This includes the purchase of Gammagard S/D 10gm and Gammagard S/D 5gm kits. The NIH CC Pharmacy is requesting the purchase of 10 bottles each of Gammagard S/D 10gm and Gammagard S/D 5gm kits and as needed to provide anticipated current patient care need. Justification: TAKEDA Group is the only responsible source for Gammagard S/D. There are multiple patients in the NIH currently on therapy with Gammagard S/D and additional patients may be transferred to the NIH for evaluation and treatment. Gammagard S/D is on the Clinical Center’s formulary, requiring a supply to be available in the Pharmacy Department at all times to support ongoing patient care. The NIH needs to keep using the same items to keep treatment consistent.
36%
Pre-Solicitation11/16/2026
Acquisition Description: This is a Notice of Intent, not a request for proposal. The National Institute of Health, Clinical Center (NIH-CC) intends to negotiate on an other than full and open competition basis with Cardinal Health. This requirement will be sole sourced to Cardinal Health under FAR 13.501(a) or 8.405-6 (b) - sole source requirements. The National Institutes of Health (NIH) Clinical Center (CC) (NIH-CC or “Program”) is a clinical research hospital providing all medical services for patients participating in human research protocols of the NIH. The CC Pharmacy department provides a range of pharmaceutical care services to inpatients and outpatients enrolled in clinical trials. The CC Pharmacy department is responsible for acquiring the supply of medications required for patient care. The NIH-CC has a pharmacy center that requires Sirturo (Bedaquiline) drug tablets for patient care. Sirturo is supplied in the following forms: 100 mg tablets in 188 count bottles and 20 mg tablets in 60 count bottles. Various different quantities are needed every year. Based on Program’s purchase history in the past, and factoring in the anticipated patient enrollment, Program expects to need approximately 12 - 36 bottles of each type of Sirturo® bottles per year. Justification: Only this Sirturo medication can be accepted as there are no substitutes for this medication. The manufacturer (Janssen Therapeutics) has designated Cardinal Health (DBA Metro Medical Supply) as the sole distributor of Sirturo in the U.S. Previous acquisitions and research indicated that this requirement should be a sole source requirement. For the previous acquisitions, Notice of Intent notices were posted on SAM.gov. Cardinal Health/Metro Medical was the only sole source provider. In order to confirm this is still applicable, this requirement was previously posted on SAM.gov as an RFQ under full and open competition under RFQ-CC-24-008485. No other companies responded, and it was confirmed by this posting that they are the sole source vendor. Previous acquisitions and research revealed this requirement should be a sole source requirement. More recently, a Request for Quotes was posted under RFQ-CC-24-008485 and it was reconfirmed that Cardinal Health/Metro Medical is the sole source vendor as they are the official authorized reseller of this equipment via their relationship with the manufacturer. Thus, Cardinal Health/Metro Medical is the only responsible and authorized source for Sirturo. Requirements: SIRTURO (BEDAQUILINE) 100 mg tablet in 188-count bottles (NDC# 59676070101) SIRTURO (BEDAQUILINE) 20 mg tablet in 60-count bottles (NDC#59676070260) Period of performance/Date of Delivery: Within 30 days of award, or mutually agreed upon. Place of Performance or Delivery: Place of Performance: NIH Clinical Center in Bethesda, MD The statutory authority for this sole source requirement is 41 U.S.C. 1901 (a) (1) as implemented by FAR 13.106-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL. All responsible sources that could provide the required may submit a capability statement that will be considered by email (subject line to reference NOI-27-000056) by 04:00 PM eastern standard time on 11/11/2026 to: lu-chang.lu@nih.gov All responses received by the closing date of this synopsis will be considered by the Government. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.
36%
Pre-Solicitation11/11/2026
Influenza Vaccine Solicitation: SPE2DP26R0003
35%
Solicitation12/03/2026

Additional Details

Solicitation Number

7571MN26R00026

Archive Date

Aug 22, 2026

Office Address

ROCKVILLE, MD, 20857